13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-07-22 Event 2026-06-30 SEC 0001493152-26-034217 →

Pershing Edward PROVECTUS BIOPHARMACEUTICALS, INC. PVCT

Stake: Shares: 52,441,275 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
4 transactions
3 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-06-30
DTC 1.00
7,766 shares short · -99.0% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-06-30 Rodrigues Dominic director, officer Award 45,860
2026-06-30 Lacey John III director Award 48,917
2026-06-30 Bailey Webster director Award 48,917
2026-04-04 Pershing Edward director, officer H

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →